Celltex Therapeutics Corp entered the industry of Medical Labs in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6215110, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.
To acquire more information, please contact David Eller, Chief Executive Officer by calling (713) 590-1000 during business hours. You can also write to the business’ Single Location at 2401 Fountain View Drive # 416, Houston, Texas TX 77057. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Celltex Therapeutics Corp |
Representative: | David Eller, Chief Executive Officer |
Place of Business: | 2401 Fountain View Drive # 416, Houston, TX 77057 |
Contact Number: | (713) 590-1000 |
Type of Service: | Medical Labs |
SIC Number: | 8071 |
NAICS Number: | 6215110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Celltex Therapeutics Corp is a company operating from Harris, Texas providing professional Medical Labs and relevant B2C variables. It was founded in 0 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 6215110 as Medical Labs.
With a current employee count of 1 to 4, Celltex Therapeutics Corp has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative David Eller, Chief Executive Officer at (713) 590-1000 for related queries, or to locate its Single Location using the coordinates 29.742165,-95.485362.
The Single Location can also be found at the street address 2401 Fountain View Drive # 416 in Houston, Texas 77057 and can be engaged online through the company website at , the company Twitter , and Facebook page .